mEq/L, K 4.0 mEq/L, Cl 110 mEq/L, C-reactive protein 8.3 mg/dL, CEA 1.1 ng/mL, and KL-6 197 U/mL (normal range: 0-499 U/mL). The Coombs test was negative. A bronchofiberscopic examination was also performed. Bronchoalveolar lavage (BAL) cells showed elevated eosinophils (34.1%) and total cell count (2.67 × 10 5 /mL). The CD4/CD8-ratio of BAL cells was 3.56 (normal range: 1.0-2.0). No specific pathogen was recognized in the BAL fluid. A diagnosis of eosinophilic pneumonia was made, and the possibility of an adverse effect of DDS as the cause of eosinophilic pneumonia was suspected. Prednisolone, 25 mg daily (0.5 mg/kg/day), was then started, and DDS was discontinued immediately. Her productive cough and fever resolved, and the infiltrative shadow on chest X-ray and thoracic CT also improved gradually ( Figure  2 ). Anemia and eosinophilia were also improved, with eosinophils of 0.2% (22/µL) and hemoglobin of 11.3 g/ dL. After three months of treatment with tapering of prednisolone, the prednisolone was discontinued. Two years later, there was no recurrence of eosinophilic pneumonia.
DISCUSSION
Drug-induced pneumonia is known as one of the major adverse effects of allergic disease and malignant When looking retrospectively, the increased circulating eosinophil count and advanced anemia were the signs for early detection of this case. Computed tomography imaging and BAL cell findings in this case were similar to those of chronic eosinophilic pneumonia (CEP) [4] . Generally, circulating eosinophil cells are not increased in the early phase of CEP cases, but they are elevated in the delayed phase [4] . In this respect, the present case was not consistent with previous reports.
From the point of view of CT findings, both CEP and bronchiolitis obliterans with organizing pneumonia (BOOP)/cryptogenic organizing pneumonia (COP) were considered in the differential diagnosis of this case. Although transbronchial lung biopsy was not performed, the present case was compatible with the criteria for eosinophilic pneumonia showing an increased number of eosinophilic cells (more than 25.0%) and an increased CD4/CD8-ratio with BAL cells [4, 5] . The present case also did not have episodes of bronchial asthma as seen in CEP. According to the previous case reports of DDS-induced eosinophilic pneumonia, an upper lobe-dominant infiltrative shadow and nonsegmental, multiple, consolidative shadows were common [2, 3] . In this regard, the present case was compatible with previous reports. The reversed halo sign on thoracic CT imaging is also known as one of the specific findings of BOOP/COP and CEP, but it was not confirmed in the present case [6] .
Although a challenge test (trying readministration of DDS) was not performed, no recurrence was seen after discontinuation of DDS. Furthermore, her anemia and eosinophilia were also improved after corticosteroid administration. Therefore, this case was diagnosed as DDS-induced eosinophilic pneumonia. The DDSinduced lymphocyte stimulation test was negative, which supported the possibility that the eosinophilic pneumonia in the present case was not mediated by a type IV allergic reaction, though it would not suggest that the present case was not DDS-induced eosinophilic pneumonia.
CONCLUSION
A rare case of DDS-induced eosinophilic pneumonia was reported. When finding a nonresolving pneumonia shadow on chest X-ray during treatment with DDS, the possibility of an adverse effect of DDS should be considered. An upper lobe-dominant infiltrative shadow and nonsegmental, multiple, consolidative shadows were characteristic findings in the present case. An increased circulating eosinophil count and advanced anemia were also useful for early diagnosis in this case. Mano Mino -Interpretation of data, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved
Keywords

